These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37858337)

  • 1. Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice.
    Martinez DR; Schäfer A; Gavitt TD; Mallory ML; Lee E; Catanzaro NJ; Chen H; Gully K; Scobey T; Korategere P; Brown A; Smith L; Parks R; Barr M; Newman A; Bowman C; Powers JM; Soderblom EJ; Mansouri K; Edwards RJ; Baric RS; Haynes BF; Saunders KO
    Cell Rep; 2023 Oct; 42(10):113248. PubMed ID: 37858337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine-mediated protection against merbecovirus and sarbecovirus challenge in mice.
    Martinez DR; Schafer A; Gavitt TD; Mallory ML; Lee E; Catanzaro NJ; Chen H; Gully K; Scobey T; Korategere P; Brown A; Smith L; Parks R; Barr M; Newman A; Bowman C; Powers JM; Mansouri K; Edwards RJ; Baric RS; Haynes BF; Saunders KO
    bioRxiv; 2023 May; ():. PubMed ID: 37293083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates.
    Liu Z; Zhou J; Wang X; Xu W; Teng Z; Chen H; Chen M; Zhang G; Wang Y; Huang J; Wang Q; Jiang S; Lu L
    Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2221713120. PubMed ID: 36897979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
    Yang X; Duan H; Liu X; Zhang X; Pan S; Zhang F; Gao P; Liu B; Yang J; Chi X; Yang W
    J Virol; 2023 Jul; 97(7):e0061023. PubMed ID: 37367229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice.
    Martinez DR; Schäfer A; Leist SR; De la Cruz G; West A; Atochina-Vasserman EN; Lindesmith LC; Pardi N; Parks R; Barr M; Li D; Yount B; Saunders KO; Weissman D; Haynes BF; Montgomery SA; Baric RS
    Science; 2021 Aug; 373(6558):991-998. PubMed ID: 34214046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice.
    Martinez DR; Schäfer A; Gobeil S; Li D; De la Cruz G; Parks R; Lu X; Barr M; Stalls V; Janowska K; Beaudoin E; Manne K; Mansouri K; Edwards RJ; Cronin K; Yount B; Anasti K; Montgomery SA; Tang J; Golding H; Shen S; Zhou T; Kwong PD; Graham BS; Mascola JR; Montefiori DC; Alam SM; Sempowski G; Sempowski GD; Khurana S; Wiehe K; Saunders KO; Acharya P; Haynes BF; Baric RS
    Sci Transl Med; 2022 Jan; 14(629):eabj7125. PubMed ID: 34726473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection.
    Tai W; Zheng J; Zhang X; Shi J; Wang G; Guan X; Zhu J; Perlman S; Du L
    Virus Res; 2023 Sep; 334():199156. PubMed ID: 37336390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination.
    Adams LE; Leist SR; Dinnon KH; West A; Gully KL; Anderson EJ; Loome JF; Madden EA; Powers JM; Schäfer A; Sarkar S; Castillo IN; Maron JS; McNamara RP; Bertera HL; Zweigert MR; Higgins JS; Hampton BK; Premkumar L; Alter G; Montgomery SA; Baxter VK; Heise MT; Baric RS
    Cell Rep; 2023 Apr; 42(4):112326. PubMed ID: 37000623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine.
    Li D; Martinez DR; Schäfer A; Chen H; Barr M; Sutherland LL; Lee E; Parks R; Mielke D; Edwards W; Newman A; Bock KW; Minai M; Nagata BM; Gagne M; Douek DC; DeMarco CT; Denny TN; Oguin TH; Brown A; Rountree W; Wang Y; Mansouri K; Edwards RJ; Ferrari G; Sempowski GD; Eaton A; Tang J; Cain DW; Santra S; Pardi N; Weissman D; Tomai MA; Fox CB; Moore IN; Andersen H; Lewis MG; Golding H; Seder R; Khurana S; Baric RS; Montefiori DC; Saunders KO; Haynes BF
    Nat Commun; 2022 Oct; 13(1):6309. PubMed ID: 36274085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes.
    Fan C; Cohen AA; Park M; Hung AF; Keeffe JR; Gnanapragasam PNP; Lee YE; Gao H; Kakutani LM; Wu Z; Kleanthous H; Malecek KE; Williams JC; Bjorkman PJ
    Immunity; 2022 Dec; 55(12):2419-2435.e10. PubMed ID: 36370711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine.
    Feng Y; Yuan M; Powers JM; Hu M; Munt JE; Arunachalam PS; Leist SR; Bellusci L; Kim J; Sprouse KR; Adams LE; Sundaramurthy S; Zhu X; Shirreff LM; Mallory ML; Scobey TD; Moreno A; O'Hagan DT; Kleanthous H; Villinger FJ; Veesler D; King NP; Suthar MS; Khurana S; Baric RS; Wilson IA; Pulendran B
    Sci Transl Med; 2023 May; 15(695):eadg7404. PubMed ID: 37163615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of variant-proof severe acute respiratory syndrome coronavirus 2, pan-sarbecovirus, and pan-β-coronavirus vaccines.
    Zhou J; Liu Z; Zhang G; Xu W; Xing L; Lu L; Wang Q; Jiang S
    J Med Virol; 2023 Jan; 95(1):e28172. PubMed ID: 36161303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
    Walls AC; Miranda MC; Schäfer A; Pham MN; Greaney A; Arunachalam PS; Navarro MJ; Tortorici MA; Rogers K; O'Connor MA; Shirreff L; Ferrell DE; Bowen J; Brunette N; Kepl E; Zepeda SK; Starr T; Hsieh CL; Fiala B; Wrenn S; Pettie D; Sydeman C; Sprouse KR; Johnson M; Blackstone A; Ravichandran R; Ogohara C; Carter L; Tilles SW; Rappuoli R; Leist SR; Martinez DR; Clark M; Tisch R; O'Hagan DT; Van Der Most R; Van Voorhis WC; Corti D; McLellan JS; Kleanthous H; Sheahan TP; Smith KD; Fuller DH; Villinger F; Bloom J; Pulendran B; Baric RS; King NP; Veesler D
    Cell; 2021 Oct; 184(21):5432-5447.e16. PubMed ID: 34619077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
    Jensen JL; Sankhala RS; Dussupt V; Bai H; Hajduczki A; Lal KG; Chang WC; Martinez EJ; Peterson CE; Golub ES; Rees PA; Mendez-Rivera L; Zemil M; Kavusak E; Mayer SV; Wieczorek L; Kannan S; Doranz BJ; Davidson E; Yang ES; Zhang Y; Chen M; Choe M; Wang L; Gromowski GD; Koup RA; Michael NL; Polonis VR; Rolland M; Modjarrad K; Krebs SJ; Joyce MG
    J Virol; 2023 Jul; 97(7):e0159622. PubMed ID: 37395646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability.
    Burnett DL; Jackson KJL; Langley DB; Aggrawal A; Stella AO; Johansen MD; Balachandran H; Lenthall H; Rouet R; Walker G; Saunders BM; Singh M; Li H; Henry JY; Jackson J; Stewart AG; Witthauer F; Spence MA; Hansbro NG; Jackson C; Schofield P; Milthorpe C; Martinello M; Schulz SR; Roth E; Kelleher A; Emery S; Britton WJ; Rawlinson WD; Karl R; Schäfer S; Winkler TH; Brink R; Bull RA; Hansbro PM; Jäck HM; Turville S; Christ D; Goodnow CC
    Immunity; 2021 Dec; 54(12):2908-2921.e6. PubMed ID: 34788600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs.
    Liu Z; Zhou J; Xu W; Deng W; Wang Y; Wang M; Wang Q; Hsieh M; Dong J; Wang X; Huang W; Xing L; He M; Tao C; Xie Y; Zhang Y; Wang Y; Zhao J; Yuan Z; Qin C; Jiang S; Lu L
    Cell Res; 2022 Mar; 32(3):269-287. PubMed ID: 35046518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
    Walls AC; Miranda MC; Pham MN; Schäfer A; Greaney A; Arunachalam PS; Navarro MJ; Tortorici MA; Rogers K; O'Connor MA; Shireff L; Ferrell DE; Brunette N; Kepl E; Bowen J; Zepeda SK; Starr T; Hsieh CL; Fiala B; Wrenn S; Pettie D; Sydeman C; Johnson M; Blackstone A; Ravichandran R; Ogohara C; Carter L; Tilles SW; Rappuoli R; O'Hagan DT; Van Der Most R; Van Voorhis WC; McLellan JS; Kleanthous H; Sheahan TP; Fuller DH; Villinger F; Bloom J; Pulendran B; Baric R; King N; Veesler D
    bioRxiv; 2021 Mar; ():. PubMed ID: 33758839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
    Liu MQ; Jiang RD; Guo J; Chen Y; Yang DS; Wang X; Lin HF; Li A; Li B; Hu B; Wang ZJ; Yang XL; Shi ZL
    J Virol; 2022 Apr; 96(8):e0016922. PubMed ID: 35343762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
    Jin H; Cheng L; Gong Y; Zhu Y; Chong H; Zhang Z; He Y
    J Virol; 2023 Aug; 97(8):e0019223. PubMed ID: 37578234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.